News
AlTi Global, Inc. (NASDAQ:ALTI) Q2 2023 Earnings Conference Call August 15, 2023 5:00 PM ET Company Participants Lily Arteaga – Head of Investor Relations...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
News
Samsonite International S.A. (OTCPK:SMSOF) Q2 2023 Earnings Conference Call August 16, 2023 9:00 PM ET Company Participants William Yue – Investor Relations Kyle Gendreau...
News
The Shopify Investment Thesis Appears Bright, Thanks To The Two Pronged Approach We previously covered Shopify (NYSE:SHOP) in May 2023, discussing the management’s decision...
News
Dear Fellow Shareholders, FPA New Income Fund (MUTF:FPNIX, the “Fund”) returned 0.21% in the second quarter of 2023 and 2.24% year-to- date through June...
News
Dear Shareholder Performance Overview The FPA Crescent Fund – Institutional Class (MUTF:FPCSX, “Fund” or “Crescent”) gained 6.29% in Q2 2023 and 16.13% in the...
News
In this series of articles, we focus on selecting and highlighting stocks that have been growing their dividends in the recent past at a...
News
Seeks Growth & Capital Preservation (Performance (%) as of 6-30-2023) QTR YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception Polen Emerging Markets...
News
As a financial coach and consultant, I provide education around the intersection of money and mental health from the position of an expert. My...
News
In the dynamic world of pharmaceuticals, Merck & Co., Inc. (NYSE:MRK) has consistently emerged as a formidable player, showcasing resilience and innovation. While recent...
News
Introduction Regeneron Pharmaceuticals (NASDAQ:REGN) is a leading biotech firm that invents, develops, manufactures, and sells medicines for serious illnesses, including eye diseases, allergies, cancer,...
